-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q+cBe5gzzsgncal/wT1r4y153z2csItsd4Mk8sVOCLiGLd+TN3v0Outhlm+oAmCB 20hxUmBEJ7YPnSVZhK88cQ== 9999999997-10-020787.txt : 20101220 9999999997-10-020787.hdr.sgml : 20101220 20101220144039 ACCESSION NUMBER: 9999999997-10-020787 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101220 DATE AS OF CHANGE: 20101220 20101220 20101220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 101262592 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5105976500 MAIL ADDRESS: STREET 1: 2100 POWELL STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C0S(#`@;V)J#3P\+TQI;F5AF4@-30O4')E=B`Y-#(V+UA29693=&T@-C@W+U)O;W0@-#0@,"!2+TEN M9F\@-B`P(%(O241;/#%#,C4W-38Q1$1&-S5#,SE$,T,P-#@T14-%-S)#,45" M/CPR-C=%0S,U,C4Q-C!#.#1!035#0SDV04-&,41$0S$T.#Y=/CX-"G-T87)T M>')E9@T*,`T*)25%3T8-"B`@(`T*-3,@,"!O8FH-/#PO3&5N9W1H(#@Q+T,@ M.#DO1FEL=&5R+T9L871E1&5C;V1E+TD@,3$Q+TP@-S,O4R`S.#X^PP`$W%\94`$3$+,P<#0P(8FQ0S$#@R\#MV#KHBG3-D9H M-L"4"ZV#:K,"8D8&!OZ-$)KI+]P`-@8&90F(*",_0(`!`'3B">(-"F5N9'-T M%LW(#,V72]$96-O9&5087)M6]U="]/;F5#;VQU;6XO4W1R=6-T5')E95)O;W0@-R`P M(%(O5'EP92]#871A;&]G+TQA;F%LP(#`@-C$R(#'1'4W1A M=&4\/"]'4S`@-3$@,"!2/CX^/B]4>7!E+U!A9V4^/@UE;F1O8FH--#8@,"!O M8FH-/#PO4W5B='EP92]4VWE!T^D.4AL[ ML>_CW'.N?1T.KK["QX]7M]/%#"SX].EZ-H7!U"[]FVY"`/=<+49K'3#T\))*&:!G(#^=_CEE0?G MS`.F5WD0(_3@F:.1VW6Q"J;?[A?A0E@,5C!9S@`].MI?T\^3Y8TQW<`[6&^$>L7I2\%G%A209.;)/:GF0JCI."(@ M]+^8!;AE\@>$]\$DO,5);T3C)I<&$`/->*Y[7F@12?@Y@+H>6(N@J@%,IB'< MS8'XMJB^TU\$OP)\"(MD:_9;)Z_CPCK0=Z-JQ(2<=9W.\CF/&2Q3$S!"@XZIC]'!=/X;]2S/ MZ[?5R(Z8M",P[9^^7[^)1E?81HAJ(Z*.E9B2`5O%=]QHT)%K MM=CJQDA[C6]>;A[TL<:+@NT@2B0-I"6[-6K+FOG(4U<1%:U'IU.,=@J>)E`F M.Y;!O3[22H21.AN#0L9^E"PO>'*`#O=)(QZB6*N,MNA%";#G@B6YL)ON(8)3 MQAYY6N9PR**D$.^V:;+G.X&+;'-.$Z@88J">Z8V;0%E2\$AWM1B*3'PAZGJ4ZT#'C2C,5'E10O,))M7.YT3T-H6F#<%AA7):$<=J2WSU(!*A1' M!L'SD6]XD4.18C9S!*ERA-^)9?P)>^3>#M#CI#R4>0$CT<4LR^R7).EI9&\> M#63T_WER'>4JC(PAY#DB)'%`Z'+8O$`K40Q"\Q394NBW5IKR^G(EV1:[)"T$$4_E!M4;O\".Y]LXS1G2W00,?)MF M.]1L7*OK%=N):]I>'>?+L-((1G%1T*X$]FD7(P;6N&T2#)Q['('+8"%4B586RQ3])7DQ,N#OA-YE?1^+%46S`A5!PV0#@ MQ#*>"G&C@[4.^4E\W7*QA3/Q_H/TV"_"\:^(T#\3H>0W-GG']UH-0MTF0)=B M))9I$QQCJVB;_>"Z=UD=M[%U3RTZ/^K,?,4Z6J*>I4L#<71!^*]E*KHF+^V\T%">V3 MZKK4IX\A#B@5I7LUC-*L=3\:`H/#DKQ7!E+U1R=654>7!E+T9O;G1$97-C$#[U4RF8R M]NMGQC.S*4A224I*JL@8A5]D,DE*45;`:,JJG)2A0E6D+)46D@PJ@T/8D!7\ M`G*#12RI`C)\M#:DP_F\(`V)`5!KV-P2MI25)6D+FVG2.&H118.7@:_!RTKX M(012TN#E14X&O`*PD&61PP>O!->`5V;PP:LD?/`J"Q^\"OD9I"#A(&4M2_@5 M4D(P*V$+12&DQF4L4M&YHH,#,4--)%V*B\:[;EAXYU">MPMS]S#,W",I<=FO MW5FS":4+DL7CQHEZ\+MEU%WV_2#&ZV:[C1H5-(>'(<8U"@DGU#&:@DW))L8+ M-8Q&L=%L#!O+ABF:*9HIFBF:*88IABF&*88IABF&*88IABF&*88IEBF6*392 M?H@+BEI1B]HM!W':=*O/)_.O5_6G+_&:\]W]]EJ&V0GRN#3MUFWGZI\-"C5I M5SOOQ+'O-^-FLW?/=T.0B'K3=*+>W6R7OMT,>W?C_.N%Q?D(SQC/)%K4OOWE M^MU^&XTZZA_$O&NNEOG7Z*#.@W8J9CX MYMY%S)O4$9X%?-T8X5IQC95YN35H2S>Z&YPG^4W&M$;K=M6),2;*>7&.VCV& MK+_[=FB[U5E_Z\2I7]SPR2-WUWOW?'2*++LANKC+*Z\>&O]J]_W04?S/(O\7 M`X[RC8C;*<;[`9J1Q."73X._GZH5V>SY]7X^-,-?Q,>U.D%K$K0V09M]0&O^ M+DB>$*!(T)8?3F9&54I3DCJ8TD*5TD-E$NZG;(HX2Q'G*>(B19S20%4EB+5, M$:L4L4X1IW10IW10IW10IW10O]_!/P(,`&+\>44-"F5N9'-T7!E+U!A9V5S M+TMI9'-;-#4@,"!273X^#65N9&]B:@TU(#`@;V)J#3P\+U-U8G1Y<&4O6$U, M+TQE;F=T:"`T,#$U+U1Y<&4O365T861A=&$^/G-TFMC.60B/SX* M/'@Z>&UP;65T82!X;6QN#IX;7!T:STB M061O8F4@6$U0($-O&UL;G,Z<&1F>#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&9X+S$N M,R\B/@H@("`@("`@("`\<&1F>#I#;VUP86YY/E-E8W5R:71I97,@86YD($5X M:&%N9V4@0V]M;6ES#I#;VUP86YY/@H@("`@("`@("`\<&1F M>#I3;W5R8V5-;V1I9FEE9#Y$.C(P,3`Q,C(P,3DQ,#,Q/"]P9&9X.E-O=7)C M94UO9&EF:65D/@H@("`@("`\+W)D9CI$97-C&UL;G,Z M>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@ M/'AA<#I#&%P.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&%P.DUO9&EF>41A=&4^ M,C`Q,"TQ,BTR,%0Q-#HS.3HT,RTP-3HP,#PO>&%P.DUO9&EF>41A=&4^"B`@ M("`@("`@(#QX87`Z0W)E871E1&%T93XR,#$P+3$R+3(P5#$T.C,Y.C0R+3`U M.C`P/"]X87`Z0W)E871E1&%T93X*("`@("`@("`@/'AA<#I-971A9&%T841A M=&4^,C`Q,"TQ,BTR,%0Q-#HS.3HT,RTP-3HP,#PO>&%P.DUE=&%D871A1&%T M93X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I M<'1I;VX@&%P34TZ M&%P34TZ"UD969A=6QT(B\^"B`@ M("`@("`@("`@(#PO2A396-U&AA M;F=E($-O;6UI')E9@T*,"`T,PT*,#`P,#`P,#`P,"`V M-34S-2!F#0HP,#`P,#`T,3@X(#`P,#`P(&X-"C`P,#`P,#0Y-3,@,#`P,#`@ M;@T*,#`P,#`P-#DX-R`P,#`P,"!N#0HP,#`P,#`U,#$Q(#`P,#`P(&X-"C`P M,#`P,#4P-C,@,#`P,#`@;@T*,#`P,#`P.3$U-2`P,#`P,"!N#0HP,#`P,#`P M,#`P(#8U-3,U(&8-"C`P,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P,#`P,"`V M-34S-2!F#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P,#`P,#`P,#`@-C4U,S4@ M9@T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P M,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`P M,#`P(#8U-3,U(&8-"C`P,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P,#`P,"`V M-34S-2!F#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P,#`P,#`P,#`@-C4U,S4@ M9@T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P M,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`P M,#`P(#8U-3,U(&8-"C`P,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P,#`P,"`V M-34S-2!F#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P,#`P,#`P,#`@-C4U,S4@ M9@T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P M,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`P M,#`P(#8U-3,U(&8-"C`P,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P,#`P,"`V M-34S-2!F#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P,#`P,#`P,#`@-C4U,S4@ M9@T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P M,#`P,#`P,#`@-C4U,S4@9@T*,#`P,#`P,#`P,"`V-34S-2!F#0IT')E9@T*,3$V#0HE)45/1@T* ` end -----END PRIVACY-ENHANCED MESSAGE-----